$MNKD Company News Puma Biotech’s blast-off is not a

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$MNKD Company News

Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer


Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook 3:47 a.m. July 24, 2014 - Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews 3:47 a.m. July 24, 2014 - Zacks.com
AFREZZA Is A Brilliant Technology Without A Compelling Marketing Story 4:20 p.m. July 23, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – INO CNC WCG MNKD 7:45 a.m. July 22, 2014 - InvestorPlace.com
5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise 9:53 a.m. July 21, 2014 - Seeking Alpha
Top Swing Trade Ideas for Monday July 21: Cliffs Natural Resources, MannKind, PolyOne 9:19 a.m. July 21, 2014 - TheStreet.com
5 Stocks With Bad Sales Growth — HTS MITT UEC LPCN MNKD 4:15 a.m. July 21, 2014 - InvestorPlace.com
Recent Tsunami of Insider Shares Purchased: A Prelude To Mannkind Partnership or Acquisition 10:22 p.m. July 19, 2014 - GuruFocus.com
Hottest Healthcare Stocks Now – IMGN MNKD CNMD NBIX 2:00 p.m. July 18, 2014 - InvestorPlace.com
Mannkind Corporation: Why Afrezza Would Completely Dominate The Insulin Market 6:22 p.m. July 16, 2014 - GuruFocus.com
Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market 11:40 a.m. July 16, 2014 - TheStreet.com
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation 4:19 p.m. July 15, 2014 - TheStreet.com
Fed Chair Yellen Says Small Biotech Stocks Over-Valued 1:10 p.m. July 15, 2014 - TheStreet.com
MannKind: Are These Top Big Pharma Companies Potential Partners? 10:15 a.m. July 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 9:30 a.m. July 14, 2014 - TheStreet.com
5 Stocks With Poor Sales Growth — HTS MITT UEC LPCN MNKD 5:30 a.m. July 14, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – AUXL OPK ARIA MNKD 1:30 p.m. July 11, 2014 - InvestorPlace.com
14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014 11:54 a.m. July 10, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – MNKD LCI NPSP PBH 1:45 p.m. July 9, 2014 - InvestorPlace.com
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. July 9, 2014 - Zacks.com


Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:02 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:02 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:01 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:02 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Class Action: What Investors Should Know

Updated Category News Views 43

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Continue Reading
Blue Friday Sales: A Princess Cruises' Steal

Updated Category News Views 194

Setting Sail on Savings: Princess Cruises' Offerings When folks start talking about Black Friday, you probably think of TVs or gadgets, but Princess Cruises is flipping that idea with their 'Blue Friday' sale, running from November 6 through December 7, 2026. Now, cruises aren't your traditional doorbuster, but a vacation might just be the kind of experience worth...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 96

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading
AZZ Inc.'s 2026 Sustainability Report: A Closer Look

Updated Category News Views 160

Diving into AZZ's Sustainability Commitment AZZ Inc., known in the trading circles as NYSE:AZZ, has just dropped its 2026 Sustainability Report and it’s quite the document to chew on. This ain't your typical corporate fluff. Tom Ferguson, the man steering the AZZ ship, laid it down plain and simple. This report isn’t just about ticking boxes for ESG; it’s reflecting...

Continue Reading
Lagoon Furniture Redefines Hospitality At BDNY 2026

Updated Category News Views 116

Revolutionizing Hospitality Design: A New Wave Some companies play it safe, sticking to tried-and-true approaches, but then there's Lagoon Furniture USA who's taking the bull by the horns with their fresh take on hospitality design ahead of BDNY 2026. Forget about following a set recipe; they're all about crafting unique identities for spaces! From Chairs to Sculptural...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 131

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 190

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 123

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
F&G Boosts Dividend for Investors in Strong Signal

Updated Category News Views 251

Ring the Bell: Dividend Hike from F&G F&G Annuities & Life (NYSE: FG) just raised its dividend, and every investor worth their salt knows that means something. A 4% bump up to $0.26 per common share might not sound like a fanfare, but in the land of finance, it's an indication that this company thinks it's riding a positive wave. It’s like getting a little bonus in your...

Continue Reading
Reliving the Legacy of Friendship at Friends & Co

Updated Category News Views 152

Reconnecting With History In an era dominated by fleeting digital interactions, the heartening effort by Friends & Co stands out. This nonprofit is digging back into its roots and asking folks to share tales of the deep bonds formed over the past fifty years under its former guise, Little Brothers – Friends of the Elderly Twin Cities. The mission? To celebrate...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating a New Beginning: Motto Mortgage Grand Opening Celebration

Updated Category News Views 128

Motto Mortgage Community Solutions: A New Era in Mortgage Brokerage Motto Mortgage Community Solutions is excited to open its doors and invite the community to celebrate a new chapter. This mortgage brokerage franchise is focused on helping individuals navigate the home loan process with ease and confidence. Inviting the Community for a Celebration The grand opening...

Continue Reading
Klarpay AG Becomes Bivial AG: A New Era in Banking Services

Updated Category News Views 227

Klarpay AG is Now Bivial AG Klarpay AG, a renowned fintech company specializing in modern Swiss accounts and global transactional banking, is undergoing a significant transformation. In the upcoming weeks, Klarpay AG will officially rebrand itself as Bivial AG. This change is not just a fresh name; it embodies the company's evolving vision and core values, integrating a...

Continue Reading
BrightSphere's Transformation: New Name and Leadership Direction

Updated Category News Views 365

BrightSphere Investment Group Inc. (NYSE: BSIG) announced its rebranding to Acadian Asset Management back in early 2025, marking a major shift in strategy. This wasn't just a name change; it was the end of their multi-boutique model and the start of a more streamlined focus on asset management. They offloaded six out of seven affiliates to zero in on core...

Continue Reading
Chippewa Boots Launches Iconic Super Logger Footwear Line

Updated Category News Views 232

Chippewa Boots Introduces the Super Logger Collection Rugged. Reliable. Ready for Anything. Chippewa Boots proudly announces the return of an icon—the legendary Super Logger. This latest evolution of one of America's most trusted work boots is assembled in the USA, using global parts. Engineered for performance and built on over a century of expert craftsmanship, the...

Continue Reading
Diodes Incorporated Q4 2024 Financial Overview: Key Insights

Updated Category News Views 237

Diodes Incorporated Reports Financial Results for Q4 2024 Diodes Incorporated (NASDAQ: DIOD) recently shared its financial performance for the fourth quarter of the fiscal year ending. The company reported a revenue of $339.3 million, marking a slight decline from $350.1 million in the previous quarter yet reflecting an increase from $322.7 million reported in Q4 of the...

Continue Reading